Axon Enterprise, Inc (NASDAQ:AXON) Shares Purchased by Diversified Trust Co

Diversified Trust Co raised its holdings in Axon Enterprise, Inc (NASDAQ:AXON - Free Report) by 18.3% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 12,492 shares of the biotechnology company's stock after purchasing an additional 1,934 shares during the quarter. Diversified Trust Co's holdings in Axon Enterprise were worth $6,570,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors also recently added to or reduced their stakes in the business. Sequoia Financial Advisors LLC lifted its holdings in shares of Axon Enterprise by 14.1% in the 1st quarter. Sequoia Financial Advisors LLC now owns 3,306 shares of the biotechnology company's stock valued at $1,739,000 after buying an additional 408 shares during the period. Robeco Institutional Asset Management B.V. raised its position in Axon Enterprise by 54.7% in the first quarter. Robeco Institutional Asset Management B.V. now owns 100,942 shares of the biotechnology company's stock worth $53,090,000 after acquiring an additional 35,699 shares in the last quarter. Perigon Wealth Management LLC raised its position in Axon Enterprise by 8.0% in the first quarter. Perigon Wealth Management LLC now owns 900 shares of the biotechnology company's stock worth $473,000 after acquiring an additional 67 shares in the last quarter. Tyche Wealth Partners LLC lifted its holdings in Axon Enterprise by 2.7% in the first quarter. Tyche Wealth Partners LLC now owns 2,447 shares of the biotechnology company's stock valued at $1,287,000 after acquiring an additional 65 shares during the period. Finally, Alpine Bank Wealth Management acquired a new stake in Axon Enterprise in the first quarter valued at $40,000. Hedge funds and other institutional investors own 79.08% of the company's stock.

Insider Transactions at Axon Enterprise

In other news, President Joshua Isner sold 905 shares of Axon Enterprise stock in a transaction dated Tuesday, June 17th. The shares were sold at an average price of $776.39, for a total transaction of $702,632.95. Following the completion of the sale, the president now directly owns 268,735 shares in the company, valued at $208,643,166.65. The trade was a 0.34% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, CEO Patrick W. Smith sold 10,000 shares of the company's stock in a transaction that occurred on Monday, April 21st. The shares were sold at an average price of $540.99, for a total transaction of $5,409,900.00. Following the transaction, the chief executive officer now directly owns 3,063,982 shares in the company, valued at $1,657,583,622.18. The trade was a 0.33% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 44,642 shares of company stock valued at $30,500,428 over the last three months. 4.40% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently weighed in on AXON shares. The Goldman Sachs Group upped their price target on shares of Axon Enterprise from $730.00 to $830.00 and gave the stock a "buy" rating in a research note on Wednesday, May 14th. Needham & Company LLC boosted their price objective on shares of Axon Enterprise from $600.00 to $750.00 and gave the stock a "buy" rating in a report on Thursday, May 8th. Bank of America upped their target price on shares of Axon Enterprise from $750.00 to $895.00 and gave the stock a "buy" rating in a research report on Wednesday, June 4th. Craig Hallum cut shares of Axon Enterprise from a "buy" rating to a "cautious" rating in a report on Monday, March 10th. Finally, Barclays boosted their price target on Axon Enterprise from $726.00 to $735.00 and gave the stock an "overweight" rating in a research note on Friday, May 9th. One investment analyst has rated the stock with a sell rating, one has issued a hold rating and ten have given a buy rating to the company's stock. Based on data from MarketBeat.com, Axon Enterprise currently has a consensus rating of "Moderate Buy" and an average target price of $699.55.

Axon Enterprise Stock Up 2.4%

AXON stock opened at $803.95 on Friday. The company has a debt-to-equity ratio of 0.68, a current ratio of 2.83 and a quick ratio of 2.62. The company's 50 day simple moving average is $709.79 and its 200-day simple moving average is $629.30. Axon Enterprise, Inc has a 12 month low of $279.02 and a 12 month high of $806.64. The firm has a market capitalization of $62.59 billion, a PE ratio of 194.19, a P/E/G ratio of 90.37 and a beta of 1.29.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last posted its earnings results on Wednesday, May 7th. The biotechnology company reported $1.41 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.34 by $0.07. The firm had revenue of $603.63 million for the quarter, compared to analyst estimates of $585.67 million. Axon Enterprise had a return on equity of 5.81% and a net margin of 14.86%. Axon Enterprise's revenue was up 31.3% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.15 EPS. Equities analysts expect that Axon Enterprise, Inc will post 5.8 earnings per share for the current fiscal year.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.

Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc (NASDAQ:AXON - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.